For these reasons, BAT is emerging as an interesting and promising target for therapeutic intervention in obesity and metabolic disease, and leptin-induced thermogenesis could be designed as a new promising strategy to counteract obesity and related metabolic derangements. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.